In a patient with diabetes, uncontrolled hypertension, hyperuricemia, and an estimated glomerular filtration rate of 16 mL/min/1.73 m², what medications are recommended?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 22, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Recommended Medications for Diabetes, Uncontrolled Hypertension, Hyperuricemia, and eGFR 16

With an eGFR of 16 mL/min/1.73 m², you cannot use metformin or initiate SGLT2 inhibitors, so focus on insulin for glycemic control, RAS blockade (ACE inhibitor or ARB) for blood pressure and kidney protection, and add a dihydropyridine calcium channel blocker and/or loop diuretic to achieve blood pressure targets below 120/80 mmHg. 1, 2

Glycemic Control

Insulin is your primary glucose-lowering agent at this level of kidney function. 2

  • Metformin is contraindicated when eGFR <30 mL/min/1.73 m² 2
  • SGLT2 inhibitors should not be initiated at eGFR <20 mL/min/1.73 m² (though if already on one, it can be continued until dialysis) 2
  • GLP-1 receptor agonists (dulaglutide or liraglutide preferred for cardiovascular benefits) can be used with caution at eGFR >15 mL/min/1.73 m², though data are limited in severe CKD 2
  • DPP-4 inhibitors are an alternative option with dose adjustment for severe CKD 2

Blood Pressure Management

Target SBP <120 mmHg based on the 2025 AHA/ACC guidelines, which showed improved cardiovascular outcomes in diabetic patients. 1

First-Line Therapy

Start with an ACE inhibitor or ARB as first-line therapy, particularly given the likely presence of albuminuria at this stage of CKD 1, 2. These agents provide:

  • Blood pressure reduction
  • Kidney protection through reduction of albuminuria
  • Cardiovascular risk reduction

Additional Agents Needed

At eGFR 16, you will almost certainly need multiple agents to achieve BP control:

  • Dihydropyridine calcium channel blocker (amlodipine, nifedipine) 2
  • Loop diuretic (furosemide, not thiazides at this eGFR) for volume management 2
  • Consider non-steroidal mineralocorticoid receptor antagonist (finerenone) if albuminuria persists despite RAS blockade and potassium is normal 2, 3

Important caveat: Monitor potassium closely with RAS inhibitors at this level of kidney function. If hyperkalemia develops, you may need to reduce the dose or add a potassium binder rather than discontinue the RAS blocker entirely, given its kidney-protective benefits.

Hyperuricemia Management

The evidence for treating asymptomatic hyperuricemia in advanced CKD is mixed, but febuxostat may slow CKD progression and help with blood pressure control. 4, 5

  • Febuxostat is better tolerated than allopurinol in advanced CKD 4
  • Studies show febuxostat can stabilize eGFR and reduce blood pressure in CKD patients with hyperuricemia 4, 5
  • Dose: Start febuxostat 40 mg daily (safe in severe CKD) 5
  • Monitor: HbA1c may increase slightly with febuxostat treatment 5

The hyperuricemia-hypertension combination appears to accelerate nephrosclerosis 6, and treating uric acid may provide additional blood pressure benefits beyond standard antihypertensive therapy 4.

Additional Cardiovascular Protection

Statin therapy is recommended for all patients with diabetes and CKD regardless of baseline lipid levels 2

Aspirin for secondary prevention if established atherosclerotic cardiovascular disease is present 2

Practical Algorithm

  1. Insulin for glycemic control (target individualized, typically HbA1c 7-8% in advanced CKD)
  2. ACE inhibitor or ARB (start low, titrate up, monitor potassium and creatinine)
  3. Dihydropyridine CCB (amlodipine 5-10 mg daily)
  4. Loop diuretic (furosemide, dose adjusted for volume status)
  5. Febuxostat 40 mg daily for hyperuricemia
  6. Statin (atorvastatin 40-80 mg or rosuvastatin 20-40 mg)
  7. Consider finerenone if albuminuria >30 mg/g persists and potassium <4.8 mEq/L

Critical Monitoring

  • Potassium every 1-2 weeks after starting/adjusting RAS inhibitors or finerenone
  • eGFR and creatinine monthly given proximity to dialysis
  • Blood pressure home monitoring daily, target <120/80 mmHg
  • Prepare for renal replacement therapy (dialysis access planning, transplant evaluation if appropriate)

References

Related Questions

In a 56-year-old woman with prediabetes (Hemoglobin A1c 6.0%), hypertension treated with telmisartan, normal estimated glomerular filtration rate (~105 mL/min/1.73 m²) and albuminuria (urine albumin‑to‑creatinine ratio ≈96 mg/g, urine micro‑albumin 141 mg/L), what is the optimal management plan to prevent chronic kidney disease progression and reduce cardiovascular risk?
In a 59-year-old man with diabetes, hypertension, obesity (BMI 35), taking amlodipine, fluoxetine, and metformin, who presents with 2 days of left foot pain, warmth, edema, and marked tenderness over the first metatarsophalangeal joint, no ulcer, markedly elevated erythrocyte sedimentation rate, and a serum uric acid of 6.6 mg/dL, what is the most likely cause of his foot pain?
For a 59-year-old, 123‑kg man with type 2 diabetes (creatinine 0.84 mg/dL, eGFR > 90 mL/min) currently on U‑500 regular insulin (115 U at breakfast, 115 U at lunch, 50 U at dinner) and receiving dexamethasone 10 mg at 16:00 and 6 mg at 14:30, what NPH (intermediate‑acting) insulin dose should be added and how should the U‑500 insulin doses be adjusted?
In a 60-year-old patient with chronic kidney disease, hypertension, type 2 diabetes, currently taking metformin, an angiotensin-converting enzyme inhibitor, and a statin, and with an atherosclerotic cardiovascular disease risk of 18%, what is the next recommended therapy?
For a 54-year-old woman with type 2 diabetes, hypertension, hypercholesterolemia, chronic kidney disease on dialysis, who presented with acute upper gastrointestinal bleeding, received one unit of packed red blood cells, and had an esophagogastroduodenoscopy showing a clean base, what post‑discharge medication regimen should be recommended?
Which occupational illness causes numbness of the upper arm and hands that is worsened by repetitive movements?
What is the appropriate treatment for facial herpes simplex lesions?
What should be included in the pre‑anesthetic evaluation of a patient with intracranial hypertension?
What medication changes should be made for a non‑diabetic patient with chronic kidney disease, hypertension, albuminuria, and hyperuricemia?
Is ceftriaxone contraindicated in any hepatic impairment?
In renal failure, when is intravenous fluid therapy indicated or contraindicated, and when should diuresis be initiated?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.